Size of the trial sample will have no bearing on the final size of an offtake.
The concrete application could easily contribute 30-60% of the EBITDA depending on tonnage.
ADN pre-DFS target of $0.26 to $0.35, page-127
-
- There are more pages in this discussion • 241 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.75M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $48.48K | 7.056M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 65 | 22147619 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 12631090 | 12 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| ADN (ASX) Chart |